Bank of America’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.43B | Sell |
22,756,646
-2,358,539
| -9% | -$189M | 0.1% | 187 |
|
|
2025
Q4 | $2.39B | Sell |
25,115,185
-8,753,856
| -26% | -$858M | 0.17% | 119 |
|
|
2025
Q3 | $3.31B | Buy |
33,869,041
+23,922
| +0.1% | +$2.48M | 0.22% | 92 |
|
|
2025
Q2 | $3.64B | Buy |
33,845,119
+2,288,065
| +7% | +$232M | 0.27% | 76 |
|
|
2025
Q1 | $3.18B | Buy |
31,557,054
+4,078,325
| +15% | +$411M | 0.26% | 77 |
|
|
2024
Q4 | $2.45B | Sell |
27,478,729
-669,930
| -2% | -$59M | 0.21% | 100 |
|
|
2024
Q3 | $2.36B | Buy |
28,148,659
+721,046
| +3% | +$56.8M | 0.19% | 114 |
|
|
2024
Q2 | $2.11B | Sell |
27,427,613
-2,534,072
| -8% | -$185M | 0.19% | 117 |
|
|
2024
Q1 | $2.05B | Buy |
29,961,685
+1,814,564
| +6% | +$117M | 0.19% | 117 |
|
|
2023
Q4 | $1.63B | Buy |
28,147,121
+2,855,942
| +11% | +$152M | 0.16% | 133 |
|
|
2023
Q3 | $1.34B | Sell |
25,291,179
-1,295,000
| -5% | -$67.9M | 0.15% | 150 |
|
|
2023
Q2 | $1.44B | Buy |
26,586,179
+1,962,736
| +8% | +$103M | 0.15% | 146 |
|
|
2023
Q1 | $1.23B | Buy |
24,623,443
+11,970,694
| +95% | +$564M | 0.13% | 171 |
|
|
2022
Q4 | $585M | Buy |
12,652,749
+785,888
| +7% | +$34M | 0.07% | 283 |
|
|
2022
Q3 | $460M | Buy |
11,866,861
+634,577
| +6% | +$25.5M | 0.05% | 322 |
|
|
2022
Q2 | $419M | Buy |
11,232,284
+1,298,155
| +13% | +$52.8M | 0.05% | 357 |
|
|
2022
Q1 | $440M | Sell |
9,934,129
-50,408
| -0.5% | -$2.18M | 0.04% | 385 |
|
|
2021
Q4 | $424M | Sell |
9,984,537
-931,256
| -9% | -$39.1M | 0.04% | 402 |
|
|
2021
Q3 | $474M | Buy |
10,915,793
+57,728
| +0.5% | +$2.55M | 0.05% | 346 |
|
|
2021
Q2 | $464M | Sell |
10,858,065
-704,195
| -6% | -$29.6M | 0.05% | 359 |
|
|
2021
Q1 | $447M | Buy |
11,562,260
+1,269,402
| +12% | +$48M | 0.05% | 344 |
|
|
2020
Q4 | $370M | Sell |
10,292,858
-233,117
| -2% | -$8.4M | 0.05% | 337 |
|
|
2020
Q3 | $402M | Buy |
10,525,975
+593,505
| +6% | +$22.9M | 0.05% | 304 |
|
|
2020
Q2 | $349M | Sell |
9,932,470
-227,372
| -2% | -$8.19M | 0.05% | 314 |
|
|
2020
Q1 | $332M | Buy |
10,159,842
+249,503
| +3% | +$9.75M | 0.06% | 284 |
|
|
2019
Q4 | $448M | Buy |
9,910,339
+1,471,212
| +17% | +$61.6M | 0.06% | 285 |
|
|
2019
Q3 | $343M | Sell |
8,439,127
-491,241
| -6% | -$20.8M | 0.05% | 341 |
|
|
2019
Q2 | $384M | Sell |
8,930,368
-474,979
| -5% | -$18.3M | 0.06% | 320 |
|
|
2019
Q1 | $361M | Sell |
9,405,347
-681,446
| -7% | -$26M | 0.06% | 314 |
|
|
2018
Q4 | $356M | Buy |
10,086,793
+1,257,847
| +14% | +$45.6M | 0.06% | 300 |
|
|
2018
Q3 | $340M | Sell |
8,828,946
-22,596
| -0.3% | -$789K | 0.05% | 335 |
|
|
2018
Q2 | $289M | Sell |
8,851,542
-76,502
| -0.9% | -$2.31M | 0.05% | 355 |
|
|
2018
Q1 | $244M | Buy |
8,928,044
+1,140,240
| +15% | +$31M | 0.04% | 403 |
|
|
2017
Q4 | $193M | Sell |
7,787,804
-1,871,905
| -19% | -$51.6M | 0.03% | 459 |
|
|
2017
Q3 | $282M | Buy |
9,659,709
+2,159,168
| +29% | +$59.6M | 0.04% | 376 |
|
|
2017
Q2 | $208M | Buy |
7,500,541
+93,980
| +1% | +$2.49M | 0.04% | 416 |
|
|
2017
Q1 | $184M | Sell |
7,406,561
-628,947
| -8% | -$15.3M | 0.04% | 435 |
|
|
2016
Q4 | $174M | Buy |
8,035,508
+355,825
| +5% | +$7.76M | 0.04% | 442 |
|
|
2016
Q3 | $183M | Sell |
7,679,683
-418,259
| -5% | -$9.98M | 0.04% | 418 |
|
|
2016
Q2 | $189M | Buy |
8,097,942
+536,957
| +7% | +$11.6M | 0.04% | 400 |
|
|
2016
Q1 | $142M | Buy |
7,560,985
+305,722
| +4% | +$5.37M | 0.03% | 473 |
|
|
2015
Q4 | $134M | Buy |
7,255,263
+512,865
| +8% | +$9.19M | 0.03% | 533 |
|
|
2015
Q3 | $111M | Buy |
6,742,398
+4,474,963
| +197% | +$76.5M | 0.03% | 601 |
|
|
2015
Q2 | $40.1M | Buy |
2,267,435
+278,721
| +14% | +$4.98M | 0.01% | 966 |
|
|
2015
Q1 | $35.3M | Sell |
1,988,714
-167,223
| -8% | -$2.64M | 0.01% | 1005 |
|
|
2014
Q4 | $28.6M | Buy |
2,155,937
+137,620
| +7% | +$1.76M | 0.01% | 1149 |
|
|
2014
Q3 | $23.8M | Buy |
2,018,317
+259,006
| +15% | +$3.26M | 0.01% | 1277 |
|
|
2014
Q2 | $22.5M | Buy |
1,759,311
+140,104
| +9% | +$1.82M | 0.01% | 1325 |
|
|
2014
Q1 | $21.9M | Buy |
1,619,207
+24,096
| +2% | +$316K | 0.01% | 1231 |
|
|
2013
Q4 | $19.2M | Buy |
1,595,111
+90,451
| +6% | +$1.07M | 0.01% | 1365 |
|
|
2013
Q3 | $17.7M | Sell |
1,504,660
-43,111
| -3% | -$466K | 0.01% | 1364 |
|
|
2013
Q2 | $14.3M | Buy |
+1,547,771
| New | +$13.1M | 0.01% | 1450 |
|
Other funds holding BSX
VCM
VPM
Bank of America's BSX Position: Q1 2026 in Review
Bank of America reduced its Boston Scientific (BSX) stake by 9.4% in Q1 2026, selling an estimated $189M and leaving 22,756,646 shares worth $1.43B. The position accounts for 0.1% of the portfolio, ranked #187.
Bank of America first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.64B in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Bank of America held 22,756,646 shares of Boston Scientific worth $1.43B as of Q1 2026.
- Bank of America sold 2,358,539 Boston Scientific shares in Q1 2026, an estimated $189M.
- Boston Scientific made up 0.1% of Bank of America's portfolio in Q1 2026, its #187 holding.
- Bank of America first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Boston Scientific position peaked at $3.64B in Q2 2025.
- 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.